Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,206 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $507.76 | 25 | $0 (2024) |
| Abbott Laboratories | $125.00 | 1 | $0 (2023) |
| Lilly USA, LLC | $98.47 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $77.72 | 5 | $0 (2022) |
| ABBVIE INC. | $63.08 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $60.83 | 3 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $60.54 | 3 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $60.27 | 3 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $49.97 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $34.77 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $157.74 | 5 | ABBVIE INC. ($63.08) |
| 2023 | $261.18 | 8 | Abbott Laboratories ($125.00) |
| 2022 | $468.95 | 22 | Novo Nordisk Inc ($308.21) |
| 2021 | $317.80 | 18 | Novo Nordisk Inc ($79.97) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $49.97 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Diabetes | ||||||
| 03/22/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: IMMUNOLOGY | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.73 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES CARE | ||||||
| 08/09/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Diabetes | ||||||
| 06/14/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Diabetes | ||||||
| 03/16/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 03/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Diabetes | ||||||
| 03/07/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes | ||||||
| 03/02/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: UROLOGY | ||||||
| 12/08/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Diabetes | ||||||
| 11/09/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Gastroenterology | ||||||
| 10/06/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Diabetes | ||||||
| 09/29/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 09/22/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Diabetes | ||||||
| 09/15/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.64 | General |
| 09/15/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $0.88 | General |
| 09/08/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Diabetes | ||||||
| 09/08/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: Diabetes | ||||||
| 08/05/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Diabetes | ||||||
| 07/29/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Diabetes | ||||||
| 07/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 288 | 307 | $13,177 | $6,874 |
| 2021 | 1 | 418 | 441 | $17,199 | $9,368 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 276 | 293 | $11,427 | $6,309 | 55.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 14 | $1,750 | $565.67 | 32.3% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 418 | 441 | $17,199 | $9,368 | 54.5% |
About Shaina Barr
Shaina Barr is a Family healthcare provider based in Bloomfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2018. The National Provider Identifier (NPI) number assigned to this provider is 1336628718.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shaina Barr has received a total of $1,206 in payments from pharmaceutical and medical device companies, with $157.74 received in 2024. These payments were reported across 53 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,206).
As a Medicare-enrolled provider, Barr has provided services to 706 Medicare beneficiaries, totaling 748 services with total Medicare billing of $16,243. Data is available for 2 years (2021–2022), covering 3 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Bloomfield, CT
- Active Since 08/07/2018
- Last Updated 06/10/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1336628718
Products in Payments
- Rybelsus (Drug) $297.23
- Ozempic (Drug) $170.39
- FREESTYLE LIBRE 3 (Device) $125.00
- MOUNJARO (Drug) $82.36
- BREZTRI (Drug) $77.72
- XARELTO (Drug) $60.83
- TRADJENTA (Drug) $60.54
- XIFAXAN (Drug) $60.27
- TRINTELLIX (Drug) $49.97
- TRELEGY ELLIPTA (Drug) $34.77
- VRAYLAR (Drug) $34.73
- SYNTHROID (Drug) $28.35
- APTIMA (Device) $25.47
- GEMTESA (Drug) $22.92
- RYBELSUS (Drug) $21.62
- APLENZIN (Drug) $18.87
- TRULICITY (Drug) $16.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Bloomfield
John Armbruster, Fnp, FNP
Family — Payments: $5,074
Sheila Armbruster, Fnp-C, FNP-C
Family — Payments: $4,381
Lisa Fritch, Aprn, APRN
Family — Payments: $2,970
Mrs. Jody Root, Fnp-Bc, FNP-BC
Family — Payments: $1,917
Mr. Scott Masullo, Np, NP
Family — Payments: $1,701
Miriam Joseph
Family — Payments: $984.18